Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer

NCT07717242 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Bladder Urothelial Carcinoma
Bladder Cancer

Interventions

DRUG: Disitamab vedotin
DRUG: Toripalimab
DRUG: Sitagliptin
DRUG: Zeprumetostat
DRUG: Tafolecimab
DRUG: Ursodeoxycholic Acid
PROCEDURE: Complete transurethral resection of bladder tumor

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]